Quick Answer
Organogenesis Holdings Inc. reported Operating Income Loss of $44.69 million for the year ending 2025.
- Organogenesis Holdings Inc. showed an increase of +3,583.6% in Operating Income Loss from 2024 to 2025.
- This data is from Organogenesis Holdings Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Organogenesis Holdings Inc.'s Operating Income Loss has grown by 177,725.0%.
- Historical annual values: Fiscal year 2025: $44.69 million | Fiscal year 2024: -$1.28 million | Fiscal year 2023: $12.53 million | Fiscal year 2022: $22.30 million | Fiscal year 2021: $72.22 million | Fiscal year 2020: $26.70 million | Fiscal year 2019: -$29.85 million | Fiscal year 2018: -$51.56 million | Fiscal year 2017: -$5.49 million | Fiscal year 2016: -$8.78 million | Fiscal year 2015: -$25.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: